An overview of new GLP-1 receptor agonists for type 2 diabetes.
about
Investigational glucagon-like peptide-1 agonists for the treatment of obesity.Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes.Cardiovascular safety and benefits of GLP-1 receptor agonists.ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin-Nicotinamide-Induced Diabetes in Rats.Liraglutide for weight management: benefits and risks.Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus.Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes.
P2860
Q38937735-6E2742D5-2180-416A-83C8-5F45F19D7A70Q39000172-0DD26682-30CC-436A-84E8-B6905DAFADEBQ39013056-EE89EFB3-28E1-4306-A8DE-E02E5F66CD29Q40954888-679D78A5-3A94-412B-B69F-10B37A353881Q47251954-153BC925-1D31-49A4-AC72-AF0CFD450ED2Q47980008-1DC18D0C-2B73-4702-9804-1B1027B67E7AQ48243435-06CE7ABE-DD93-46AE-A2B8-9F192FEABA24Q51249870-7791AA54-362C-4B0F-8F68-61734FEBD566
P2860
An overview of new GLP-1 receptor agonists for type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An overview of new GLP-1 receptor agonists for type 2 diabetes.
@en
type
label
An overview of new GLP-1 receptor agonists for type 2 diabetes.
@en
prefLabel
An overview of new GLP-1 receptor agonists for type 2 diabetes.
@en
P2093
P2860
P1476
An overview of new GLP-1 receptor agonists for type 2 diabetes.
@en
P2093
Brian Tomlinson
Yuzhen Zhang
Zhong-Min Liu
P2860
P304
P356
10.1517/13543784.2016.1123249
P407
P577
2015-11-20T00:00:00Z